## Note
nid: 1496029620681
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::!FLAG_THESE_CARDS::!DELETE, #AK_Step1_v11::#B&B::08_Endocrinology::05_Other::04_Signaling_Pathways, #AK_Step1_v11::#FirstAid::04_Pathology::03_Neoplasia::08_Oncogenes, #AK_Step1_v11::#FirstAid::04_Pathology::03_Neoplasia::08_Oncogenes::Growth_Factor_Receptors::*Basics, #AK_Step1_v11::#FirstAid::04_Pathology::03_Neoplasia::08_Oncogenes::Growth_Factors::*Basics, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::20_Sorafenib_Sunitinib, #AK_Step1_v11::#OME_banner::Clinical::07_Endocrinology, #AK_Step1_v11::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::01_Imatinib,_erlotinib,_sorafenib,_sunitinib,_vemurafenib::zanki_extra, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^HighYield::3-HighYield-temporary
markdown: false

### Text
<div>
  The abbreviation <b>RTK</b> stands for {{c1::<b>Receptor Tyrosine
  Kinase</b>}}
</div>

### Extra
Tyrosine Kinases come in receptor variants (ex EGF) and non receptor variants (ex Cytokines)

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-37280316129283%20(1).jpg"><img src=
"paste-323204878958595.jpg"><img src=
"paste-326542068547587.jpg"><img src="paste-330222855520259.jpg">
<!--EndFragment-->

### Sketchy
<img src="paste-386186279387137.jpg"><img src=
"paste-6ef6236c9786ccaaf69cacfab716239d037e3c2e.png">

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/endocrinology?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_6.png"></a>
</div>

### Additional Resources


### One by one

